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CASE REPORTSA life-threatening umbrellaElodie Saillen, MD,a Christian Latremouille, MD,b,c Jacques Pouchot, MD,a,c and
Brigitte Ranque, MD, PhD,a,c Paris, FrancePercutaneous device closure of atrial septal defects has been
increasingly used during the last 30 years because of its
ease and relative safety.1,2 Various complications have been
reported but remain uncommon. Most of them occur in the
first days after implantation. We report here late aortic and
left atrial perforation by occluder struts, complicated
by acute cardiac tamponade, 28 months after device
implantation. Our report illustrates the possibility of late
life-threatening complications of percutaneous atrial devices.CLINICAL SUMMARY
A 22-year-old woman was seen for acute chest pain. She
had been treated with prednisone (8 mg daily) for a anti–cy-
clic citrullinated peptide antibody rheumatoid arthritis
since the age of 17 years, with the recent addition of oral
methotrexate (15 mg weekly). She also had a history of se-
cundum atrial septal defect of 11 mm successfully treated
28 months previously by percutaneous closure with
a 20-mm CARDIA occluder (Atriasept ASD; Cardia,
Eagan, Minn), a double-umbrella device with left- and
right-sided struts (arms).
At her admission, the patient was afebrile and in hemody-
namically stable condition. There was isolated jugular ve-
nous distention. Her electrocardiogram showed a 120
beats/min sinus tachycardia, and laboratory findings re-
vealed anemia (hemoglobin 10.9 g/dL). Chest radiography
appeared normal; however, echocardiography demon-
strated a pericardial effusion of 28 mm width with evidence
of right ventricular compression. Subxiphoid pericardial
drainage removed 150 mL of bloody pericardial fluid under
pressure. Pericardial fluid culture results were negative, and
a pericardial biopsy sample was unremarkable. Immediate
outcome was favorable, and a diagnosis of viral or connec-
tive tissue–related pericarditis was considered. The patient
was given oral colchicine (1 mg daily). Persistent tachycar-
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graphic scan suggested the protrusion of a device’s strut
through the right atrial wall and the aorta, which was con-
firmed by transesophageal echocardiography.
The patient was rapidly taken for surgery. One of the oc-
cluder’s struts was indeed perforating the aortic root, and
another was perforating the lateral wall of the right atrium
(Figure 1). The occluder was removed, and the atrial septal
defect was closed with a heterologous pericardium patch.
Perforations of the aorta and right atrium were fixed with
cross stitches. Postoperative outcome was uneventful, and
after 6 months of follow-up, the patient remained free of
symptoms.DISCUSSION
Closure of atrial septal defects with various percutaneous
devices has been increasingly used during the last 30 years
as an alternative to conventional open surgical repair be-
cause of the ease and the relative safety of the procedure.1,2
Various complications, including device migration,
thromboembolism, significant residual shunt, arrhythmia,
aortic or atrial perforations, and device erosion, have been
reported but remain uncommon. Most complications
(70%) occur within the first 3 days after implantation.3 Se-
rious complications requiring surgery have been reported
for 2.3% to 8% of all types of atrial septal defect closure
devices.1,2 Perforations are extremely rare and specifically
involve anterosuperior atrial walls or adjacent aorta.4,5 Of
note, a quarter of such perforations occur late, from 3
weeks to 3 years after the closure,4 and there has even
been a report of a device erosion associated with Amplatzer
device placement after 6 years.5
Our patient had been treated with prednisone for a few
years; however, this therapy is unlikely to have played an
important role in the complication because of the low daily
dose administered. Furthermore, there is no evidence of
a higher incidence of percutaneous device complications
among patients receiving corticosteroids. Nevertheless, cor-
ticosteroids are known to alter tissues healing and may have
helped to worsen the injury provoked by the device.
We report here late aortic and left atrial perforation by
occluder struts, complicated by acute cardiac tamponade, oc-
curring 28months after the implantationof a double-umbrella
occluding device. Our report illustrates the possibility of life-
threatening complications of percutaneous atrial devices even
several years after the closure. Prolonged caution is therefore
warranted for patients inwhomatrial septal defects have been
treated with a transcatheter occlusion device.rdiovascular Surgery c Volume 145, Number 6 e53
FIGURE 1. Operative findings.A, Intraoperative photograph shows perforation of the right atriumbyanoccluder strut (arrow). B, Intraoperative photograph
shows atrial septal occluder in situ, before removal (visualized through the opened right atrium).C, The removed device can be seen clearly in this photograph.
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aspiration in mediastinal abscessesYen-Fu Chen, MD,a Chao-Chi Ho, MD, PhD,b Chung-Yu Chen, MD,a and Chong-Jen Yu, MD, PhD,b
Douliou City and Taipei, TaiwanMediastinal abscess is a serious condition carrying a high
mortality and requiring surgical intervention. Real-time en-
dobronchial ultrasonographically guided transbronchial
needle aspiration (EBUS-TBNA), which is used for obtain-
ing mediastinal tissue samples, is a safer and less invasive
method than surgery.1 Here we present 2 cases of patients
with mediastinal abscess diagnosed by EBUS-TBNA and
discuss the related issues.ery c June 2013
